References

Alldredge B A comparison of lorazepam, diazepam, and placebo for the treatment of out-of-hospital status epilepticus. N Engl J Med. 2001; 345:(9)631-7

Appleton R, Macleod S, Martland T Drug management for acute tonic-clonic convulsions including convulsive status epilepticus in children. Cochrane Database of Syst Rev. 2008; 16:(3)

Arendt R In vitro correlates of benzodiazepine cerebrospinal fluid uptake, pharmacodynamic action and peripheral distribution. J Pharmacol Exp Ther. 1983; 227:(1)98-106

Bigham B, Welsford M Applying hospital evidence to paramedicine: issues of indirectness, validity and knowledge translation. CJEM. 2015; 17:(3)281-5

Breimer D, Jochemsen R, von Albert H Pharmacokinetics of benzodiazepines. Short-acting versus long-acting. Arzneimittel-Forschung. 1980; 30:(5a)875-881

Burstein A, Modica R, Hatton M, Forrest A, Gengo F Pharmacokinetics and pharmacodynamics of midazolam after intranasal administration. J Clin Pharmacol. 1997; 37:(8)711-18

Brigo F, Bragazzi N, Bacigaluppi S Is intravenous lorazepam really more effective and safe than intravenous diazepam as first-line treatment for convulsive status epilepticus? A systematic review with meta-analysis of randomized controlled trials. Epilepsy and Behavior. 2016; 64:29-36

Cloyd J A single-blind, crossover comparison of the pharmacokinetics and cognitive effects of a new diazepam rectal gel with intravenous diazepam. Epilepsia. 1998; 39:(5)520-26

Cock H, Schapira A A comparison of lorazepam and diazepam as initial therapy in convulsive status epilepticus. QJM. 2002; 95:(4)225-31

Dreifuss F A comparison of rectal diazepam gel and placebo for acute repetitive seizures. N Engl J Med. 1998; 338:(26)1869-75

EBSCO. CINAHL Database, The Database Coverage List [online] Ebscohost.com.. 2016. https//www.ebscohost.com/titleLists/cin-coverage.htm (Accessed 17 October 2016)

Fountain N, Lothman E Pathophysiology of status epilepticus. J Clin Neurophysiol. 1995; 12:(4)326-42

Goodkin H, Kapur J Responsiveness of status epilepticus to treatment with diazepam decreases rapidly as seizure duration increases. Epilepsy Curr. 2003; 3:(1)11-2

Gottwald M Pre-hospital stability of diazepam and lorazepam. Am J Emerg Med. 1999; 17:(4)333-7

Greenblatt D, Divoll M Diazepam versus lorazepam: relationship of drug distribution to duration of clinical action. Adv Neurol. 1983; 34:487-91

Greenblatt D Pharmacokinetic comparison of sublingual lorazepam with intravenous, intramuscular, and oral lorazepam. J Pharm Sci. 1982; 71:(2)248-52

Greenblatt D Pharmacokinetic and electroencephalographic study of intravenous diazepam, midazolam, and placebo. Clin Pharmacol Ther. 1989; 45:(4)356-65

Human Medicine Regulations.London: The Stationery Office; 2012

Joint Formulary Committee.London: BMJ Group and Pharmaceutical Press; 2016

UK ambulance services clinical practice guidelines 2013.Bridgwater: Class Professional Publishing; 2016

Knoester P Pharmacokinetics and pharmacodynamics of midazolam administered as a concentrated intranasal spray. A study in healthy volunteers. Br J Clin Pharmacol. 2002; 53:(5)501-7

Leppik l Double-blind study of lorazepam and diazepam in status epilepticus. JAMA. 1983; 249:(11)

Lombroso C Intermittent home treatment of status and clusters of seizures. Epilepsia. 1989; 30:(s2)S11-S14

Lowenstein D, Cloyd J Out-of-hospital treatment of status epilepticus and prolonged seizures. Epilepsia. 2007; 48:(s8)96-8

Malinovsky J Plasma concentrations of midazolam after I.V., nasal or rectal administration in children. Br J Anaesth. 1993; 70:(6)617-20

Mitchell W, Crawford T Lorazepam is the treatment of choice for status epilepticus. J Epilepsy. 1990; 3:(1)7-10

Prasad K, Al-Roomi K, Krishnan P Anticonvulsant therapy for status epilepticus. Br J Clin Pharmacol. 2007; 63:(6)640-647

Roche. 2007. http//www.roche.com/rochea_z.pdf (Accessed 17 October 2016)

Rogalski R, Rogalski A Benzodiazepine Selection in the Management of Status Epilepticus. Advanced Emergency Nursing Journal. 2015; 37:(2)83-94

Scott R Buccal absorption of midazolam: pharmacokinetics and EEG pharmacodynamics. Epilepsia. 1998; 39:(3)290-4

Shorvon S Status epilepticus: its clinical features and treatment in children and adults.Cambridge: Cambridge University Press; 1994

Silbergleit R Intramuscular versus intravenous therapy for pre-hospital status epilepticus. N Engl J Med. 2012; 366:(7)591-600

Treiman D Pharmacokinetics and clinical use of benzodiazepines in the management of status epilepticus. Epilepsia. 1989; 30:(s2)S4-S10

Treiman D A Comparison of four treatments for generalized convulsive status epilepticus. N Engl J Med. 1998; 339:(12)792-8

Trinka E Benzodiazepines used primarily for emergency treatment (diazepam, lorazepam and midazolam), Third Edition. Oxford: Wiley-Blackwell; 2009

Wermeling D Bioavailability and pharmacokinetics of lorazepam after intranasal, intravenous, and intramuscular administration. Journal Clin Pharmacol. 2001; 41:(11)1225-31

Is diazepam or lorazepam the most effective benzodiazepine for use in paramedic management of convulsive seizures in adults?

02 November 2016
Volume 8 · Issue 11

Abstract

Diazepam, a drug from the benzodiazepine family, has been used for the acute management of status epilepticus outside of hospital since its introduction in 1963 (Roche, 2007). Although known to be an effective treatment for the termination and subsequent prophylaxis of seizures (Dreifuss et al, 1998), there have been a number of developments in benzodiazepine production since its emergence, leading to the discovery of alternative agents.

The Human Medicines Regulations (2012) provides registered paramedics with legal exemption in relation to the administration of diazepam, but does not allow for the autonomous use of any other benzodiazepine medications. Therefore, unless patient specific or patient group directions exist, diazepam remains the only benzodiazepine generally available to ambulance clinicians despite the presence of alternatives that may be more effective. This article compares and contrasts the available literature regarding the qualities of diazepam with those of lorazepam in the setting of managing convulsive status epilepticus.

The authors found that lorazepam is often reported to be more effective in terminating seizures than diazepam. Lorazepam may offer a more effective, safer and cheaper treatment option for the management of seizures in the pre-hospital environment.

Managing prolonged seizures in the pre-hospital setting is an undertaking that presents significant challenges to clinicians. Patients can present with airway and breathing compromise, transport can be dangerous and there is the potential for refractory (medication resistant) status epilepticus, which has been shown to become more likely as ‘onset to drug’ time increases (Goodkin and Kapur, 2003).

Medications of the benzodiazepine class are psychoactive, all acting to increase the effect of the inhibitory neurotransmitter gamma-aminobutyric acid (GABA). Pertinent to pre-hospital care is the potent anti-convulsant effect of these medications, the efficacy of which varies across different formulations, which are further categorised depending on their duration of action.

National Ambulance Service guidelines stipulate that the first-line paramedic-led treatment for generalised seizures lasting in excess of 5 minutes should be 10 mg of intravenous diazepam, with the per rectum (PR) route considered where intravenous (IV) access is difficult (Joint Royal Colleges Ambulance Liaison Committee, 2016). Diazepam is known to be effective in the termination of seizures in 50% to 80% of cases (Treiman, 1989), although the drug redistributes into adipose tissue quickly, and as such has a short duration of action of approximately 20 minutes (Greenblatt and Divoll, 1983). In addition, it has been shown that seizure recurrence occurs in up to 50% of patients, leading to the administration of repeat diazepam doses (Cock, 2002).

Subscribe to get full access to the Journal of Paramedic Practice

Thank you for visiting the Journal of Paramedic Practice and reading our archive of expert clinical content. If you would like to read more from the only journal dedicated to those working in emergency care, you can start your subscription today for just £48.

What's included

  • CPD Focus

  • Develop your career

  • Stay informed